AACHEN, Germany & CAMBRIDGE, England--(BUSINESS WIRE)--The biopharmaceutical company PAION AG (ISIN DE000A0B65S3; Frankfurt Stock Exchange, Prime Standard: PA8; London AIM: PAI) today reported its financial results according to International Financial Reporting Standards (IFRS) for the nine months ended 30 September 2008.
